INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07RJRubinstein Julie0B / 37S37 trades$6.38M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
8,700 sh
May 18, 2026May 20, 2026
Page 787 of 1737
← PrevNext →
traded May 18, 2026
+2d
SEC Form 4

Evidence

13
YM
Yan MingDirector, CHIEF TECHNOLOGY OFFICER
CTKBCytek Biosciences, Inc.
Option exercise
M—
4,108 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
BV
Barnett ValerieCHIEF LEGAL OFFICER
CTKBCytek Biosciences, Inc.
Option exercise
M—
9,435 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$3,501
761 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

13
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$21K
4,486 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$2,800
608 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

13
VD
Van Well DaanChief Legal Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$3,149
684 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

13
JW
Jiang WenbinDirector, PRESIDENT AND CEO
CTKBCytek Biosciences, Inc.
Option exercise
M—
19.3K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
6,320 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
BV
Barnett ValerieCHIEF LEGAL OFFICER
CTKBCytek Biosciences, Inc.
Option exercise
M—
7,250 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$16K
669 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
OT
O'Brien Robert TDirector
TILEINTERFACE INC
Grant or award
A—
4,461 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

13
BP
Busque PhilippeSVP, GLOBAL SALES AND SERVICES
CTKBCytek Biosciences, Inc.
Option exercise
M—
5,551 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
KR
Kappus Anthony RayGM & Chief Operating Officer
UPWKUPWORK, INC
Option exercise
M—
5,114 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
10.7K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
ML
Mariucci Anne LDirector
CTRICenturi Holdings, Inc.
Option exercise
M—
7,338 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
GE
Gessert EricaChief Financial Officer
UPWKUPWORK, INC
Option exercise
M—
37.5K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

12
NA
Niewiara James ASVP, GENERAL COUNSEL
MSIMotorola Solutions, Inc.
Gift
G—
166 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

12
SM
Singh MohitCHIEF DEVELOPMENT OFFICER
QSQuantumScape Corp
Tax withholding
F$234K
31.9K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

12
CS
Congdon David SDirector, Executive Chairman
ODFLOLD DOMINION FREIGHT LINE, INC.
Gift
G—
73.7K sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

12
GC
Guttman-McCabe ChristopherChief Reg & Comm Officer
ATEXAnterix Inc.
Tax withholding
F$81K
1,426 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

12
TK
Talluri Rajendra KDirector, President and CEO
ENVXEnovix Corp
Tax withholding
F$105K
17.6K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

12
GM
Googe MatthewGeneral Counsel
MCFTMasterCraft Boat Holdings, Inc.
Grant or award
A$75K
3,250 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

12
JW
Jiang WenbinDirector, PRESIDENT AND CEO
CTKBCytek Biosciences, Inc.
Tax withholding
F$53K
15.0K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

11
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$200K
800 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

11
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$249K
1,100 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

11
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$1.13M
150.2K sh
May 20, 2026May 20, 2026
traded May 20, 2026
+0dSEC Form 4

Evidence

11
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$95K
423 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

11
RN
Reskos NikolaosChief Operating Officer
SBLKStar Bulk Carriers Corp.
Open-market sale · 10b5-1 plan
SELL$870K
33.1K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

10
KS
Kereere SuzanPresident, Global Markets
PYPLPayPal Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$8,973
200 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

9
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Tax withholding
F$14K
3,839 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Tax withholding
F$8,051
2,268 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
LR
Liu Yi RayCHIEF FINANCIAL OFFICER
SESSES AI Corp
Grant or award
A—
331.9K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
DD
DeMaria DustinDirector
CTRICenturi Holdings, Inc.
Grant or award
A—
7,736 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

9
SR
Smith Albert Randolph IIDirector
ODFLOLD DOMINION FREIGHT LINE, INC.
Grant or award
A—
859 sh
May 20, 2026May 20, 2026
traded May 20, 2026
+0dSEC Form 4

Evidence

9
HS
Haller Karen SDirector
CTRICenturi Holdings, Inc.
Option exercise
M—
7,338 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
DJ
Dill JulieDirector
CTRICenturi Holdings, Inc.
Option exercise
M—
7,338 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
GV
Gupta VikramSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$79K
692 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

9
GR
Gabosch Bradley RDirector
ODFLOLD DOMINION FREIGHT LINE, INC.
Grant or award
A—
859 sh
May 20, 2026May 20, 2026
traded May 20, 2026
+0dSEC Form 4

Evidence

9
BP
Busque PhilippeSVP, GLOBAL SALES AND SERVICES
CTKBCytek Biosciences, Inc.
Option exercise
M—
5,551 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence